Fieldpoint Private Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $102K | Sell |
1,046
-42
| -4% | -$4.1K | 0.03% | 363 |
|
|
2022
Q1 | $102K | Buy |
1,088
+55
| +5% | +$5.16K | 0.02% | 434 |
|
|
2021
Q4 | $88K | Sell |
1,033
-20
| -2% | -$1.7K | 0.02% | 466 |
|
|
2021
Q3 | $101K | Hold |
1,053
| – | – | 0.02% | 413 |
|
|
2021
Q2 | $92K | Buy |
1,053
+17
| +2% | +$1.49K | 0.02% | 436 |
|
|
2021
Q1 | $101K | Sell |
1,036
-301
| -23% | -$29.3K | 0.02% | 402 |
|
|
2020
Q4 | $128K | Buy |
+1,337
| New | +$128K | 0.03% | 359 |
|